<DOC>
	<DOCNO>NCT00719511</DOCNO>
	<brief_summary>Evaluation patch specific immunotherapy allergic patient</brief_summary>
	<brief_title>Study Specific Allergen Immunotherapy Grass Pollen Allergic Subjects Epicutaneous Allergen Administration</brief_title>
	<detailed_description />
	<criteria>Inclusion criterion : Written inform consent History grass pollen allergic rhinitis Male female 18 year 65 year Positive skinprick test grass pollen Positive conjunctival provocation test Exclusion criterion : Eczematous skin lesion upper arm Perennial allergic rhinitis Symptoms infectious disease rhinitis last 2 week Surgical intervention last 30 day Pregnancy nurse History HIV AIDS History mastocytosis ( cutaneous systemic ) History significant cardiovascular disease Hypertension ( blood pressure &gt; 160 / 95 ) History significant pulmonary , renal and/or hepatic disease History significant hematological disorder Moderate severe asthma History malignancy History neurological psychiatric disease History autoimmune disease Antihistamines long halflives last week Systemic topical steroid 5 day Active infectious disease Contraindicated medication : immunosuppressive agent Betablockers ACEinhibitors , AT 2 Antagonists tricyclic antidepressant daily use Betaagonists steroid inhaler Participation another clinical trial /study moment within last 60 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Rhinoconjunctivitis</keyword>
	<keyword>Allergic</keyword>
</DOC>